Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.25 (
MEKK1
)
1,856
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Certain small GTP-binding proteins control the enzymatic activity of a family of closely related serine-threonine kinases known as mitogen-activated protein kinases (MAPKs). In turn, these MAPKs, such as p44(mapk) and p42(mapk), referred to herein as MAPKs, and stress-activated protein kinases, also termed c-Jun N-terminal kinases (JNKs), phosphorylate and regulate the activity of key molecules that ultimately control the expression of genes essential for many cellular processes. Whereas Ras controls the activation of MAPK, we and others have recently observed that two members of the Rho family of small GTP-binding proteins, Rac1 and Cdc42, regulate the activity of JNKs. The identity of molecules communicating Rac1 and Cdc42 to JNK is still poorly understood. It has been suggested that Pak1 is the most upstream kinase connecting these GTPases to JNK; however, we have observed that coexpression of Pak1 with activated forms of Cdc42 or Rac1 diminishes rather than enhances JNK activation. This prompted us to explore the possibility that kinases other than Pak might participate in signaling from GTP-binding proteins to JNK. In this regard, a computer-assisted search for proteins containing areas of homology to that in Pak1 that is involved in binding to Rac1 and Cdc42 led to the identification of
mixed lineage kinase 3
(
MLK3
), also known as protein-tyrosine kinase 1, as a potential candidate for this function. In this study, we found that
MLK3
overexpression is sufficient to activate JNK potently without affecting the phosphorylating activity of MAPK or p38. Furthermore, we present evidence that
MLK3
binds the GTP-binding proteins Cdc42 and Rac1 in vivo and that
MLK3
mediates activation of
MEKK
-SEK-JNK kinase cascade by Rac1 and Cdc42. Taken together, these findings strongly suggest that members of the novel MLK family of highly related kinases link small GTP-binding proteins to the JNK signaling pathway.
...
PMID:Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family. 891 Feb 92
Transforming growth factor beta (TGF-beta)-activated kinase (TAK1) is known for its involvement in TGF-beta signaling and its ability to activate the p38-mitogen-activated protein kinase (MAPK) pathway. This report shows that TAK1 is also a strong activator of c-Jun N-terminal kinase (JNK). Both the wild-type and a constitutively active mutant of TAK1 stimulated JNK in transient transfection assays. Mitogen-activated protein kinase kinase 4 (MKK4)/stress-activated protein kinase/extracellular signal-regulated kinase (SEK1), a dual-specificity kinase that phosphorylates and activates JNK, synergized with TAK1 in activating JNK. Conversely, a dominant-negative (MKK4/SEK1 mutant inhibited TAK1-induced JNK activation. A kinasedefective mutant of TAK1 effectively suppressed hematopoietic progenitor kinase-1 (HPK1)-induced JNK activity but had little effect on germinal center kinase activation of JNK. There are two additional MAPK kinase kinases,
MEKK1
and
mixed lineage kinase 3
(
MLK3
), that are also downstream of HPK1 and upstream of MKK4/SEK mutant. However, because the dominant-negative mutants of
MEKK1
and
MLK3
did not inhibit TAK1-induced JNK activity, we conclude that activation of JNK1 by TAK1 is independent of
MEKK1
and
MLK3
. In addition to TAK1, TGF-beta also stimulated JNK activity. Taken together, these results identify TAK1 as a regulator in the HPK1 --> TAK1 --> MKK4/SEK1 --> JNK kinase cascade and indicate the involvement of JNK in the TGF-beta signaling pathway. Our results also suggest the potential roles of TAK1 not only in the TGF-beta pathway but also in the other HPK1/JNK1-mediated pathways.
...
PMID:Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction. 927 37
Mixed lineage kinase 3
(
MLK3
) is a serine/threonine protein kinase that functions as a
mitogen-activated protein kinase kinase kinase
to activate the c-Jun NH(2)-terminal kinase pathway.
MLK3
has also been implicated as an I kappa B kinase kinase in the activation of NF-kappa B. Amino-terminal to its catalytic domain,
MLK3
contains a Src homology 3 (SH3) domain. SH3 domains harbor three highly conserved aromatic amino acids that are important for ligand binding. In this study, we mutated one of these corresponding residues within
MLK3
to deliberately disrupt the function of its SH3 domain. This SH3-defective mutant of
MLK3
exhibited increased catalytic activity compared with wild type
MLK3
suggesting that the SH3 domain negatively regulates
MLK3
activity. We report herein that the SH3 domain of
MLK3
interacts with full-length
MLK3
, and we have mapped the site of interaction to a region between the zipper and the Cdc42/Rac interactive binding motif. Interestingly, the SH3-binding region contains not a proline-rich sequence but, rather, a single proline residue. Mutation of this sole proline abrogates SH3 binding and increases
MLK3
catalytic activity. Taken together, these data demonstrate that
MLK3
is autoinhibited through its SH3 domain. The critical proline residue in the SH3-binding site of
MLK3
is conserved in the closely related family members, MLK1 and MLK2, suggesting a common autoinhibitory mechanism among these kinases. Our study has revealed the first example of SH3 domain-mediated autoinhibition of a serine/threonine kinase and provides insight into the regulation of the mixed lineage family of protein kinases.
...
PMID:Autoinhibition of mixed lineage kinase 3 through its Src homology 3 domain. 1159 Jan 55
Mixed lineage kinase 3
(
MLK3
) is a
mitogen-activated protein kinase kinase kinase
(
MAPKKK
) that activates c-jun N-terminal kinase (JNK) and can induce cell death in neurons. By contrast, the activation of phosphatidylinositol 3-kinase and AKT/protein kinase B (PKB) acts to suppress neuronal apoptosis. Here, we report a functional interaction between
MLK3
and AKT1/PKBalpha. Endogenous
MLK3
and AKT1 interact in HepG2 cells, and this interaction is regulated by insulin. The interaction domain maps to the C-terminal half of
MLK3
(amino acids 511-847), and this region also contains a putative AKT phosphorylation consensus sequence. Endogenous JNK, MKK7, and
MLK3
kinase activities in HepG2 cells are significantly attenuated by insulin treatment, whereas the phosphatidylinositol 3-kinase inhibitors LY294002 and wortmannin reversed the effect. Finally,
MLK3
-mediated JNK activation is inhibited by AKT1. AKT phosphorylates
MLK3
on serine 674 both in vitro and in vivo. Furthermore, the expression of activated AKT1 inhibits
MLK3
-mediated cell death in a manner dependent on serine 674 phosphorylation. Thus, these data provide the first direct link between
MLK3
-mediated cell death and its regulation by a cell survival signaling protein, AKT1.
...
PMID:Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival. 1245 7
Mixed lineage kinase 3
(
MLK3
) functions as a
mitogen-activated protein kinase kinase kinase
to activate multiple mitogen-activated protein kinase pathways. Our current studies demonstrate that lack of
MLK3
blocks signaling of activated Cdc42 to c-Jun N-terminal kinase, giving strong support for the idea that Cdc42 is a physiological activator of
MLK3
. We show herein that Cdc42, in a prenylation-dependent manner, targets
MLK3
from a perinuclear region to membranes, including the plasma membrane. Cdc42-induced membrane targeting of
MLK3
is independent of
MLK3
catalytic activity but depends upon an intact Cdc42/Rac-interactive binding motif, consistent with
MLK3
membrane translocation being mediated through direct binding of Cdc42. Phosphorylation of the activation loop of
MLK3
requires
MLK3
catalytic activity and is induced by Cdc42 in a prenylation-independent manner, arguing that Cdc42 binding is sufficient for activation loop autophosphorylation of
MLK3
. However, membrane targeting is necessary for full activation of
MLK3
and maximal signaling to JNK. We previously reported that
MLK3
is autoinhibited through an interaction between its N-terminal SH3 domain and a proline-containing sequence found between the leucine zipper and the CRIB motif of
MLK3
. Thus we propose a model in which GTP-bound Cdc42/Rac binds
MLK3
and disrupts SH3-mediated autoinhibition leading to dimerization and activation loop autophosphorylation. Targeting of this partially active
MLK3
to membranes likely results in additional phosphorylation events that fully activate
MLK3
and its ability to maximally signal through the JNK pathway.
...
PMID:Cdc42 induces activation loop phosphorylation and membrane targeting of mixed lineage kinase 3. 1625 96
Mixed lineage kinase 3
(
MLK3
) is a
mitogen-activated protein kinase kinase kinase
member that activates the c-Jun N-terminal kinase (JNK) pathway. Aberrant activation of
MLK3
has been implicated in neurodegenerative diseases. Similarly, glycogen synthase kinase (GSK)-3beta has also been shown to activate JNK and contribute to neuronal apoptosis. Here, we show a functional interaction between
MLK3
and GSK-3beta during nerve growth factor (NGF) withdrawal-induced cell death in PC-12 cells. The protein kinase activities of GSK-3beta,
MLK3
, and JNK were increased upon NGF withdrawal, which paralleled increased cell death in NGF-deprived PC-12 cells. NGF withdrawal-induced cell death and
MLK3
activation were blocked by a GSK-3beta-selective inhibitor, kenpaullone. However, the MLK family inhibitor, CEP-11004, although preventing PC-12 cell death, failed to inhibit GSK-3beta activation, indicating that induction of GSK-3beta lies upstream of
MLK3
. In GSK-3beta-deficient murine embryonic fibroblasts, ultraviolet light was unable to activate
MLK3
kinase activity, a defect that was restored upon ectopic expression of GSK-3beta. The activation of
MLK3
by GSK-3beta occurred via phosphorylation of
MLK3
on two amino acid residues, Ser(789) and Ser(793), that are located within the C-terminal regulatory domain of
MLK3
. Furthermore, the cell death induced by GSK-3beta was mediated by
MLK3
in a manner dependent on its phosphorylation of the specific residues within the C-terminal domain by GSK-3beta. Taken together, our data provide a direct link between GSK-3beta and
MLK3
activation in a neuronal cell death pathway and identify
MLK3
as a direct downstream target of GSK-3beta. Inhibition of GSK-3 is thus a potential therapeutic strategy for neurodegenerative diseases caused by trophic factor deprivation.
...
PMID:Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3. 1771 61
Cysteine-rich secretory protein 2 (CRISP2) is a testis-enriched protein localized to the sperm acrosome and tail. CRISP2 has been proposed to play a critical role in spermatogenesis and male fertility, although the precise function(s) of CRISP2 remains to be determined. Recent data have shown that the CRISP domain of the mouse CRISP2 has the ability to regulate Ca(2+) flow through ryanodine receptors (RyR) and to bind to
MAP kinase kinase kinase
11 (
MAP3K11
). To further define the biochemical pathways within which CRISP2 is involved, we screened an adult mouse testis cDNA library using a yeast two-hybrid assay to identify CRISP2 interacting partners. One of the most frequently identified CRISP2-binding proteins was gametogenetin 1 (GGN1). Interactions occur between the ion channel regulatory region within the CRISP2 CRISP domain and the carboxyl-most 158 amino acids of GGN1. CRISP2 does not bind to the GGN2 or GGN3 isoforms. Furthermore, we showed that Ggn1 is a testis-enriched mRNA and the protein first appeared in late pachytene spermatocytes and was up-regulated in round spermatids before being incorporated into the principal piece of the sperm tail where it co-localized with CRISP2. These data along with data on RyR and
MAP3K11
binding define the CRISP2 CRISP domain as a protein interaction motif and suggest a role for the GGN1-CRISP2 complex in sperm tail development and/or motility.
...
PMID:Characterization of gametogenetin 1 (GGN1) and its potential role in male fertility through the interaction with the ion channel regulator, cysteine-rich secretory protein 2 (CRISP2) in the sperm tail. 1850 91
Mixed lineage kinase 3
(
MLK3
) is a
MAP3K
that activates the JNK-dependent MAPK pathways. Here, we show that
MLK3
is required for cell migration in a manner independent of its role as a
MAP3K
or
MLK3
kinase activity. Rather,
MLK3
functions in a regulated way to limit levels of the activated GTPase Rho by binding to the Rho activator, p63RhoGEF/GEFT, which, in turn, prevents its activation by Galphaq. These findings demonstrate a scaffolding role for
MLK3
in controlling the extent of Rho activation that modulates cell migration. Moreover, they suggest that
MLK3
functions as a network hub that links a number of signaling pathways.
...
PMID:MLK3 limits activated Galphaq signaling to Rho by binding to p63RhoGEF. 1885 32
Mixed lineage kinase 3
(
MLK3
) is a
mitogen-activated protein kinase kinase kinase
(
MAP3K
) that activates multiple mitogen-activated protein kinase (MAPK) pathways in response to growth factors, stresses and the pro-inflammatory cytokine, tumor necrosis factor (TNF).
MLK3
is required for optimal activation of stress activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling by TNF, however, the mechanism by which
MLK3
is recruited and activated by the TNF receptor remains poorly understood. Here we report that both TNF and interleukin-1 beta (IL-1 beta) stimulation rapidly activate
MLK3
kinase activity. We observed that TNF stimulates an interaction between
MLK3
and TNF receptor associated factor (TRAF) 2 and IL-1 beta stimulates an interaction between
MLK3
and TRAF6. RNA interference (RNAi) of traf2 or traf6 dramatically impairs
MLK3
activation by TNF indicating that TRAF2 and TRAF6 are critically required for
MLK3
activation. We show that TNF also stimulates ubiquitination of
MLK3
and
MLK3
can be conjugated with lysine 48 (K48)- and lysine 63 (K63)-linked polyubiquitin chains. Our results suggest that K48-linked ubiquitination directs
MLK3
for proteosomal degradation while K63-linked ubiquitination is important for
MLK3
kinase activity. These results reveal a novel mechanism for
MLK3
activation by the pro-inflammatory cytokines TNF and IL-1 beta.
...
PMID:Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6. 1958 14
Mixed lineage kinase 3
(
MLK3
) is a mitogen activated protein kinase kinase kinase (
MAP3K
) that activates multiple MAPK signaling pathways. Nuclear factor kappa B (NF-kappaB) is a transcription factor that has important functions in inflammation, immunity and cell survival. We found that silencing mlk3 expression with RNA interference (RNAi) in SKOV3 human ovarian cancer epithelial cells and NIH-3T3 murine fibroblasts led to a reduction in the level of the inhibitor of kappa B alpha (IkappaBalpha) protein. In addition, we observed enhanced basal IkappaB kinase (IKK) activity in HEK293 cells transiently transfected with
MLK3
siRNA and in NIH3T3 cells stably expressing
MLK3
shRNA (shMLK3). Furthermore, the basal level of NF-kappaB-dependent gene transcription was elevated in shMLK3 cells. Silencing mlk3 expression conferred resistance of cells to etoposide-induced apoptotic cell death and overexpression of wild type
MLK3
(MLK3-WT) or kinase-dead
MLK3
(MLK3-KD) promoted apoptotic cell death and cleavage of poly (ADP-ribose) polymerase (PARP). Overexpression of
MLK3
-WT or
MLK3
-KD enhanced etoposide-induced apoptotic cell death and cleavage of PARP. These data suggest that
MLK3
functions to limit IKK activity, and depleting
MLK3
helps protect cells from etoposide-induced cell death through activation of IKK-dependent signaling.
...
PMID:Mixed lineage kinase 3 negatively regulates IKK activity and enhances etoposide-induced cell death. 1978 5
1
2
3
Next >>